These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8991075)

  • 21. Detailed review of transgenic rodent mutation assays.
    Lambert IB; Singer TM; Boucher SE; Douglas GR
    Mutat Res; 2005 Sep; 590(1-3):1-280. PubMed ID: 16081315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of shuttle vectors for mutation analysis in transgenic mice and rats.
    Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM
    Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic animal models for detection of in vivo mutations.
    Mirsalis JC; Monforte JA; Winegar RA
    Annu Rev Pharmacol Toxicol; 1995; 35():145-64. PubMed ID: 7598490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene.
    Baross-Francis A; Milhausen MK; Andrew SE; Jevon G; Jirik FR
    Carcinogenesis; 2000 Jun; 21(6):1259-62. PubMed ID: 10837019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of mutations in transgenic animal models: BigBlue and Muta Mouse.
    Schmezer P; Eckert C
    IARC Sci Publ; 1999; (146):367-94. PubMed ID: 10353395
    [No Abstract]   [Full Text] [Related]  

  • 27. Selecting chemicals and assays for assessing mammalian germ cell mutagenicity.
    Shelby MD
    Mutat Res; 1996 Jun; 352(1-2):159-67. PubMed ID: 8676905
    [No Abstract]   [Full Text] [Related]  

  • 28. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.
    Boerrigter ME
    Environ Mol Mutagen; 1998; 32(2):148-54. PubMed ID: 9776177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A lacZ transgenic mouse assay for the detection of mutations in follicular granulosa cells.
    Yauk CL; Gingerich JD; Soper L; MacMahon A; Foster WG; Douglas GR
    Mutat Res; 2005 Oct; 578(1-2):117-23. PubMed ID: 16039675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial consideration for use of transgenic mutation assays in a regulatory submission.
    Sofuni T; Suzuki T; Hayashi M
    Environ Mol Mutagen; 1996; 28(4):443-6. PubMed ID: 8991076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
    Stuart GR; Holcroft J; de Boer JG; Glickman BW
    Cancer Res; 2000 Jan; 60(2):266-8. PubMed ID: 10667573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel germline mutation in Big Blue mice.
    Crabbe RA; Prtenjaca A; Tarnowski HE; Hill KA
    Environ Mol Mutagen; 2009 Mar; 50(2):114-20. PubMed ID: 19107908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinction of mutagenic carcinogens from a mutagenic noncarcinogen in the big blue transgenic mouse.
    Cunningham ML; Hayward JJ; Shane BS; Tindall KR
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):683-6. PubMed ID: 8781405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards validation of the Big Blue transgenic mouse mutagenesis assay: the mutational spectrum of ex vivo pinpoint mutant plaques.
    Nishino H; Buettner VL; Sommer SS
    Mutat Res; 1996 Nov; 372(1):97-105. PubMed ID: 9003536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic animal mutation models: a review of the models and how they function.
    Dean S
    Methods Mol Biol; 2012; 817():377-97. PubMed ID: 22147581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection by dietary compounds against mutation in a transgenic rodent.
    de Boer JG
    J Nutr; 2001 Nov; 131(11 Suppl):3082S-6S. PubMed ID: 11694652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pros and cons of transgenic mouse mutagenesis test systems.
    Gahlmann R
    J Exp Anim Sci; 1993 Sep; 35(5-6):232-43. PubMed ID: 8218438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Of mice and mutants: target size and sensitivity.
    Skopek TR
    Mutat Res; 1995 Oct; 331(2):225-8. PubMed ID: 7500981
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology.
    Ashby J; Tinwell H
    Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow and liver mutagenesis in lacZ transgenic mice treated with hexavalent chromium.
    Itoh S; Shimada H
    Mutat Res; 1998 Jan; 412(1):63-7. PubMed ID: 9508365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.